Saksena S - Search Results

1

Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.

Saksena S, Poczobutt-Johanos M, Castle LW, Fogoros RN, Alpert BL, Kron J, Pacifico A, Griffin J, Ruskin JN, Kehoe RF, et al. Saksena S, et al. J Am Coll Cardiol. 1992 Mar 1;19(3):490-9. doi: 10.1016/s0735-1097(10)80260-8. J Am Coll Cardiol. 1992. PMID: 1537999 Clinical Trial.

2

Teaching objectives for fellowship programs in clinical electrophysiology.

Scheinman M, Akhtar M, Brugada P, Denes P, Garan H, Griffin JC, Rosen M, Saksena S, Woosley R. Scheinman M, et al. Among authors: saksena s. J Am Coll Cardiol. 1988 Jul;12(1):255-61. doi: 10.1016/0735-1097(88)90383-x. J Am Coll Cardiol. 1988. PMID: 3379212 Free article. No abstract available.

3

Experience with a third-generation implantable cardioverter-defibrillator.

Saksena S, Mehta D, Krol RB, Tullo NG, Saxena A, Kaushik R, Neglia J. Saksena S, et al. Am J Cardiol. 1991 Jun 15;67(16):1375-84. doi: 10.1016/0002-9149(91)90468-z. Am J Cardiol. 1991. PMID: 2042568

4

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky EN. Pacifico A, et al. Among authors: saksena s. N Engl J Med. 1999 Jun 17;340(24):1855-62. doi: 10.1056/NEJM199906173402402. N Engl J Med. 1999. PMID: 10369848 Free article. Clinical Trial.

5

Current application of implantable cardioverter-defibrillators in the management of malignant ventricular tachyarrhythmias.

Saksena S. Saksena S. Cardiology. 1990;77(3):181-94. doi: 10.1159/000174600. Cardiology. 1990. PMID: 2272056

6

Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia.

Saksena S, Pantopoulos D, Parsonnet V, Rothbart ST, Hussain SM, Gielchinsky I. Saksena S, et al. Am J Cardiol. 1986 Jul 1;58(1):70-4. doi: 10.1016/0002-9149(86)90243-2. Am J Cardiol. 1986. PMID: 3728334

7

Evaluation of treatment strategies of malignant ventricular tachyarrhythmias in the era of the implantable defibrillator.

Domanski MJ, Saksena S. Domanski MJ, et al. Among authors: saksena s. Am J Cardiol. 1993 Aug 15;72(5):455-7. doi: 10.1016/0002-9149(93)91140-d. Am J Cardiol. 1993. PMID: 8352189 No abstract available.

8

Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverter-defibrillators.

Tullo NG, Saksena S, Krol RB, Mauro AM, Kunecz D. Tullo NG, et al. Among authors: saksena s. Am J Cardiol. 1990 Aug 15;66(4):411-5. doi: 10.1016/0002-9149(90)90695-w. Am J Cardiol. 1990. PMID: 2386116

9

Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention.

Delfaut P, Saksena S, Prakash A, Krol RB. Delfaut P, et al. Among authors: saksena s. J Am Coll Cardiol. 1998 Dec;32(7):1900-8. doi: 10.1016/s0735-1097(98)00489-6. J Am Coll Cardiol. 1998. PMID: 9857870 Free article. Clinical Trial.

10

Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads.

Saksena S, An H, Mehra R, DeGroot P, Krol RB, Burkhardt E, Mehta D, John T. Saksena S, et al. Am J Cardiol. 1992 Aug 1;70(3):304-10. doi: 10.1016/0002-9149(92)90609-3. Am J Cardiol. 1992. PMID: 1632393 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

632 results

Search Page

Filters